We are live on
!
Find out more
Aristotle Capital Management Portfolio holdings
AUM
$47.7B
1-Year Est. Return
13.92%
This Fund
S&P 500
This Quarter
Est. Return
-12.24%
1 Year Est. Return
+13.92%
3 Year Est. Return
+50.48%
5 Year Est. Return
+59.96%
10 Year Est. Return
+301.3%
AUM
$14.8B
AUM Growth
-$2.35B
(-14%)
Cap. Flow
-$64.6M
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
32.21%
Holding
182
New
9
Increased
31
Reduced
96
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$156M |
| 2 |
Parker-Hannifin
PH
|
+$90.6M |
| 3 |
Honeywell
HON
|
+$59.4M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$48.3M |
| 5 |
PNC Financial Services
PNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$51.4M |
| 2 |
GE Aerospace
GE
|
+$42.2M |
| 3 |
AbbVie
ABBV
|
+$37.9M |
| 4 |
Danaher
DHR
|
+$20.4M |
| 5 |
PPG Industries
PPG
|
+$19.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.49% |
| 2 | Healthcare | 16.46% |
| 3 | Technology | 16.25% |
| 4 | Consumer Staples | 9.06% |
| 5 | Industrials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Morgan Stanley
MS
$324B
| $28.9M | 0.2% |
730,000
| – | – |
|
52
Accenture
ACN
$119B
| $16.9M | 0.11% |
119,583
-804
| -0.7% | -$127K |
|
53
iShares MSCI EAFE ETF
EFA
$78.2B
| $14.3M | 0.1% |
244,032
+238,461
| +4,280% | +$14.9M |
|
54
Sensata Technologies
ST
$6.02B
| $14.1M | 0.1% |
315,126
+22,652
| +8% | +$1.03M |
|
55
Coca-Cola Europacific Partners
CCEP
$46.1B
| $13.2M | 0.09% |
287,553
-549
| -0.2% | -$25.4K |
|
56
Brookfield
BN
$84B
| $9.05M | 0.06% |
661,792
-20,516
| -3% | -$306K |
|
|
DASTY
57
DELISTED
DASSAULT SYSTEMES SA ADR
DASTY
| $8.61M | 0.06% |
72,600
-3,228
| -4% | -$383K |
|
|
NJ
58
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
| $8.02M | 0.05% |
282,192
-24,194
| -8% | -$688K |
|
59
TotalEnergies
TTE
$201B
| $7.6M | 0.05% |
145,678
-2,578
| -2% | -$148K |
|
60
VF Corp
VFC
$5.14B
| $6.63M | 0.04% |
98,717
| – | – |
|
61
Abbott
ABT
$178B
| $6.46M | 0.04% |
89,290
| – | – |
|
62
ORIX
IX
$41.5B
| $6.04M | 0.04% |
421,945
-25,640
| -6% | -$402K |
|
63
Johnson & Johnson
JNJ
$642B
| $5.69M | 0.04% |
44,088
-200
| -0.5% | -$27.9K |
|
|
KUB
64
DELISTED
KUBOTA CORPORATION (ONE ADS REP 5 SHS COM)
KUB
| $5.51M | 0.04% |
77,397
-4,500
| -5% | -$320K |
|
|
AKZOY
65
DELISTED
Akzo Nobel NV
AKZOY
| $5.5M | 0.04% |
205,221
-46,033
| -18% | -$1.23M |
|
66
ING
ING
$105B
| $5.46M | 0.04% |
+511,963
| New | +$6.15M |
|
67
UBS Group
UBS
$162B
| $5.22M | 0.04% |
421,976
-100,278
| -19% | -$1.36M |
|
68
Cameco
CCJ
$40.6B
| $4.72M | 0.03% |
416,235
-26,838
| -6% | -$311K |
|
|
BF
69
DELISTED
BASF AKTIENGESELLT ADS(RP1 ORD
BF
| $4.58M | 0.03% |
264,377
-62,073
| -19% | -$1.08M |
|
70
PepsiCo
PEP
$186B
| $4.51M | 0.03% |
40,807
| – | – |
|
71
SLB Ltd
SLB
$79.1B
| $4.26M | 0.03% |
118,095
-15,031
| -11% | -$742K |
|
72
Lennar Class B
LEN.B
$19B
| $3.75M | 0.03% |
125,970
-1,423
| -1% | -$46.8K |
|
73
Pfizer
PFE
$158B
| $3.53M | 0.02% |
85,294
| – | – |
|
74
ExxonMobil
XOM
$679B
| $3.4M | 0.02% |
49,868
-70
| -0.1% | -$5.49K |
|
75
Church & Dwight Co
CHD
$22.4B
| $3.27M | 0.02% |
49,666
| – | – |
|
Similar funds
SCP
VCMC
EP
Aristotle Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Aristotle Capital Management held 182 positions worth $14.8B, down 14% from $17.2B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Aristotle Capital Management's Q4 2018 filing shows 9 new, 31 increased, 96 reduced and 10 closed positions. Its largest new stake was Honeywell: 435,090 shares worth $54.2M. The largest sale was Novartis, an estimated $51.4M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Technology.
- Aristotle Capital Management's largest Q4 2018 buy was Honeywell: 435,090 shares worth $54.2M.
- Aristotle Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $156M increase.
- Aristotle Capital Management's biggest Q4 2018 reduction was Novartis, cutting an estimated $51.4M.
- Aristotle Capital Management fully exited GE Aerospace in Q4 2018, selling an estimated $42.2M.
- Aristotle Capital Management's ten largest holdings make up 32% of its $14.8B portfolio in Q4 2018.
- Aristotle Capital Management opened 9 new positions and closed 10 in Q4 2018.
- Aristotle Capital Management's portfolio value fell 14% quarter-over-quarter to $14.8B.
Based on Aristotle Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.